BridgeMD
New treatment option for Prostate Cancer
Official title Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy
ClinicalTrials.gov ID: NCT03830788
What this study is testing
- What it's testing
- The TEMPOS-GEniToUrinary Group (GETUG) study is a multicenter, medico-economic study comparing brachytherapy to SBRT in low and intermediate risk prostate cancer, particularly focused on the issue of erectile dysfunction. A total of 240 potent patients are randomized in two arms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Main Biopsy proven prostate adenocarcinoma,
- Low risk prostate cancer according to d'Amico (T1-T2a and PSA \<10 ng/ml, and Gleason score 6) or intermediate risk prostate cancer according d'Amico...
- Indication of a curative treatment by brachytherapy validated in multidisciplinary consultation meeting, Main
You likely can't join if
- Androgen deprivation therapy,
- Contraindication for prostate Iodine 125 brachytherapy (Prostate volume \> 50 cc, impossibility if general anesthesia).
- Contraindication for Resonance Magnetic Imagery (RMI) (claustrophobia, pacemaker)
- Participation to another research which could have an impact on the study treatment and the outcomes
The study team makes the final eligibility decision.
Where it's taking place
- Albi, France
- Angers, France
- Bordeaux, France
- Dijon, France
- La Garenne-Colombes, France
- Levallois-Perret, France
- Lyon, France
- Montpellier, France
- Paris, France
- Pierre-Bénite, France
- Reims, France
- Rennes, France
- Saint-Doulchard, France
- Saint-Herblain, France
- Saint-Priest-en-Jarez, France
- Toulouse, France
- Tours, France
- Vandœuvre-lès-Nancy, France
- Villejuif, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Albi, France; Angers, France; Bordeaux, France; Dijon, France; La Garenne-Colombes, France; Levallois-Perret, France and 13 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.